Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction WASH Q1 2026 Earnings EPS Misses Estimates Stock Slips 074 OLP Q1 2026 Earnings EPS Surpasses Estimates as Management Highlights Portfolio Performance WAVE Q1 2026 Earnings Strong EPS Beat Amid No Revenue Stock Declines AFBI Q3 2023 Earnings Modest EPS of 025 Amid Quiet Quarter